[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100375023":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":39,"responsibleParty":81,"collaborators":83,"id":87,"slug":18,"hasResults":88,"nctId":89,"briefTitle":90,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":88,"sex":93,"minAge":94,"maxAge":18,"enrollmentInfo":95,"targetDuration":18,"studyType":98,"phases":99,"briefSummary":101,"conditions":102,"keywords":105,"overallStatus":42,"whyStopped":18,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Ottawa Heart Institute Research Corporation","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Quit Card Intervention (QCI)","EXPERIMENTAL","Study intervention group.",[13],"Behavioral: Quit Card Intervention (QCI)",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care (UC)","NO_INTERVENTION","Study control group.",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"BEHAVIORAL","The intervention is comprised of a behavioural incentive in the form of a gift card as well as tailored smoking cessation counseling. Eligible consenting smokers randomized to the QCI group will receive: a \"Quit Card\" (a gift card worth $300 that can be used to buy nicotine replacement therapies at any pharmacy); self-help information; and, enrollment in six months of telephone follow-up support tailored by treatment goal with a Nicotine Addiction Treatment Specialist.",[9],[25],{"name":26,"affiliation":5,"role":27},"Kerri-Anne Mullen, PhD","PRINCIPAL_INVESTIGATOR",[29,35],{"name":30,"role":31,"phone":32,"phoneExt":33,"email":34},"Chantelle Masterson, BPhil","CONTACT","613-696-7000","19157","cmasterson@ottawaheart.ca",{"name":36,"role":31,"phone":32,"phoneExt":37,"email":38},"Evyanne Wooding, R.Kin","17596","ewooding@ottawaheart.ca",[40,57,64,71],{"facility":41,"status":42,"city":43,"state":44,"zip":18,"country":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Civic Hospital","RECRUITING","Ottawa","Ontario","Canada",{"type":47,"coordinates":48},"Point",[49,50],-75.69812,45.41117,{"lat":50,"lon":49},[53],{"name":54,"role":31,"phone":55,"phoneExt":18,"email":56},"Dr. Venkatesh Thiruganasambandamoorthy","6137985555,17023","vthirug@toh.ca",{"facility":58,"status":42,"city":43,"state":44,"zip":18,"country":45,"cosmosGeoPoint":59,"geoPoint":61,"contacts":62},"General Hospital",{"type":47,"coordinates":60},[49,50],{"lat":50,"lon":49},[63],{"name":54,"role":31,"phone":55,"phoneExt":18,"email":56},{"facility":65,"status":42,"city":43,"state":44,"zip":18,"country":45,"cosmosGeoPoint":66,"geoPoint":68,"contacts":69},"Riverside Hospital",{"type":47,"coordinates":67},[49,50],{"lat":50,"lon":49},[70],{"name":54,"role":31,"phone":55,"phoneExt":18,"email":56},{"facility":72,"status":42,"city":43,"state":44,"zip":18,"country":45,"cosmosGeoPoint":73,"geoPoint":75,"contacts":76},"University of Ottawa Heart Institute",{"type":47,"coordinates":74},[49,50],{"lat":50,"lon":49},[77],{"name":78,"role":31,"phone":79,"phoneExt":18,"email":80},"Dr. Kerri-Anne Mullen","613-696-7000 ext.19095","KMullen@ottawaheart.ca",{"type":82,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[84],{"name":85,"class":86},"Canadian Institutes of Health Research (CIHR)","OTHER_GOV","100375023",false,"NCT04163081","The INITIATE Study: Initiating Nicotine Dependence Treatment for Smokers Admitted to Emergency Departments","INITIATE","Inclusion Criteria:\n\n* Current daily smoker (smokes ≥ 5 cigarettes per day);\n* ≥ 18 years of age (the age of majority in Ontario);\n* For ED sites only, assigned a CTAS level of 2-5 (emergent to non-urgent);\n* Able to read and understand English or French;\n* Resides in Ontario and eligible for Ontario Health Insurance Plan (to permit linkage with administrative data housed at the Institute for Clinical Evaluative Sciences \\[ICES\\]);\n* Available and willing to participate in follow-up assessments over the next 12 months;\n* Has access to a telephone or computer;\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Currently participating in this or another smoking cessation study;\n* For ED sites only, assigned a CTAS level of 1 (resuscitation - the most seriously ill patients with highest likelihood of hospital admission) or in psychiatric emergency unit;\n* Pregnant, planning to become pregnant over the next year, or breastfeeding;\n* Has morbid illness which will prevent completion of 26-week follow-up (e.g., receiving palliative care);\n* In the opinion of the attending physician, manifests acute physical and\u002For psychiatric illness or has cognitive impairment that would preclude participation in\u002Fbenefit from the intervention.\n* Scheduled for a known elected surgery, procedure, or future hospitalization during the study period.","ALL","18 Years",{"count":96,"type":97},1208,"ESTIMATED","INTERVENTIONAL",[100],"NA","The INITIATE Study is a randomized controlled trial that is testing an intervention designed to increase long-term abstinence among tobacco smokers seen in emergency departments (ED) and other high-volume hospital and community ambulatory care settings. The intervention includes a behavioural incentive and tailored follow-up support on long-term smoking abstinence, health, healthcare utilization, and cost. Tobacco-related illnesses cost the healthcare system millions each year. Quitting smoking improves smoking-related outcomes, like the onset or management of heart disease, stroke, lung diseases, and several cancers. There are approximately 16 million visits to Canadian EDs each year; an estimated 3-4 million of these involve smokers. Effective quit smoking interventions exist, but are underutilized. Few hospital EDs, community healthcare centers, and other inpatient and outpatient clinics in Canada offer tobacco-use interventions. In order for clinicians to offer quit smoking support, interventions need to be simple given the realities of these high-volume environments. Considering that stopping smoking improves health outcomes, that tobacco-use is an important cause of preventable ED use, and the volume of smokers, Canadian EDs and other high-volume hospital and community ambulatory care settings are a missed opportunity in the initiation of quit smoking support. Our intervention has been designed to optimize uptake and smoking abstinence by including the most effective evidence-based behavioural and drug-related approaches, removing specific barriers and challenges that smokers face when trying to quit (e.g., affordability, low confidence and motivation), while packaging the intervention in a quick-to-initiate manner, making it ideal for fast-paced, complex environments.",[103,104],"Nicotine Dependence, Cigarettes","Nicotine Withdrawal",[106,107,108,109,110,111],"Nicotine Replacement Therapy","Emergency Department","Nicotine Dependence","Tobacco Abstinence","Tobacco Treatment","Cigarette","2026-04-29",{"date":114,"type":115},"2026-05-06","ACTUAL",{"date":117,"type":115},"2022-04-19",{"date":119,"type":97},"2027-03",{"name":5,"class":6},4]